Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -97,905 | -61,140 | -29,511 | -84,969 | -56,529 |
| Depreciation Amortization | -4,977 | -2,765 | -1,766 | -5,606 | -2,947 |
| Accounts receivable | -4,193 | 768 | -193 | -513 | -1,096 |
| Accounts payable and accrued liabilities | 4,593 | 1,589 | -1,500 | 8,191 | 5,911 |
| Other Working Capital | 4,244 | 1,389 | -1,663 | -351 | 71 |
| Other Operating Activity | 16,161 | 8,637 | 7,003 | 5,068 | 3,854 |
| Operating Cash Flow | $-82,077 | $-51,522 | $-27,630 | $-78,180 | $-50,736 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -159,961 | 41,309 | 82,142 | -286,707 | -263,628 |
| PPE Investments | -75 | -70 | -24 | -105 | -74 |
| Purchase Of Investment | N/A | N/A | -67,324 | N/A | N/A |
| Investing Cash Flow | $-160,036 | $41,239 | $14,794 | $-286,812 | $-263,702 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 275,413 | 728 | 160 | 40,290 | 614 |
| Other Financing Activity | -171 | 1 | 1 | 215,333 | 215,333 |
| Financing Cash Flow | $275,242 | $729 | $161 | $255,623 | $215,947 |
| Beginning Cash Position | 23,022 | 23,022 | 23,022 | 132,391 | 132,391 |
| End Cash Position | 56,151 | 13,468 | 10,347 | 23,022 | 33,900 |
| Net Cash Flow | $33,129 | $-9,554 | $-12,675 | $-109,369 | $-98,491 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,077 | -51,522 | -27,630 | -78,180 | -50,736 |
| Capital Expenditure | -75 | -70 | -24 | -105 | -74 |
| Free Cash Flow | -82,152 | -51,592 | -27,654 | -78,285 | -50,810 |